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The primary objective of this research involves the synthetic design of homologs of 3, 4-
dihydroxyphenylalanine (dopa) in order to inhibit melanin formation, melanogenesis. These 
synthetic homologs are structured to have variations within their side chains and unto their 
aromatic ring when compared to the structure of dopa. Strategic structural variations are 
incorporated within the molecular framework of the homologs such that their dopa mimicking 
features are enhanced, and consequently inhibit the formation of melanins. The structural 
variations of the homologs are designed to exhibit specificity in the regulations of phase-I and 
phase –II of melanogenesis. Many studies have suggested a strong correlation between enhanced 
rates of melanin formation and many forms of malignant melanomas (e.g., skin cancers). In this 
work, a variety of dopa precursors and dopa homologs were successfully synthesized. The 
synthetic methods developed for the preparation of the dopa homologs were also designed for 
efficient entry into a variety of new amino acids and precursors. Structural validation of dopa and 
precursors were aided by the use of a variety of instrumentations; inclusive of GC/MS, FTIR and 
NMR. The ultimate success of this work is expected to lead to the development of a more 










Melanin, a redox biopolymer pigment plays an important role in the pigmentation of skin 
in mammals (Sulaimon & Kitchell, 2003). Melanin is produced in melanocytes and 
catecholaminergic neurons by a process called melanogenesis (Solano, Hearing, & García-
Borrón, 1999). Melanocytes are the type of cells present in the skin, eyes, hair, ear, mucous 
membranes and in the central nervous system (Jimbow, 1998). Melanin in melanocytes is 
synthesized within highly specialized membrane bound intracellular organelles called 
melanosomes. In the epidermis of the skin, melanocytes deliver melanin to keratinocytes 
providing skin pigmentation, hair and feather coloration (Sulaimon & Kitchell, 2003). Skin 
complexion is related to the density of the melanocytes, the number, size and dispersion of 
melanosomes, the nature of the pigment and its degradation rate. Melanosomes in darker 
individuals are known to be larger in size (Solano, et al., 1999).  
Mammalian melanin is composed of two pigments, eumelanin and pheomelanin 
respectively (Ito, 2003). Eumelanins are dark brown to black in color and are characterized as 
insoluble nitrogenous pigments responsible for skin coloration (Potterf et al., 1999). Eumelanin 
consists of 5, 6- dihydroxyindole (DHI) and 5,6-dihydroxyindole-2-carboxylic acid units in 
reduced or oxidized states (Ito, 2003). Pheomelanin is yellow to red colored alkali soluble 
chromophore responsible for feather coloration and some shades of hair (Potterf, et al., 1999). 
Pheomelanin mainly consists of benzothiazole units (Ito, 2003). The interaction between 
eumelanins and pheomelanins gives rise to the most common type of melanins called mixed 
melanins (Park et al., 2004). 
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Melanogenesis is a biochemical pathway for the melanin production that occurs in 
melanosomes (Sulaimon & Kitchell, 2003). During the development of melanin, melanosomes 
acquire three metallozymes in its production. These metallozymes are tyrosinase (tyr-ase), 
tyrosinase-related protein 1 (Tyr 1) and tyrosinase-related protein 2 (Tyr 2) (Hartmeyer et al., 
1997). Of the three enzymes, tyr-ase plays the most critical role in melanogenesis (Tsukamoto, 
Jackson, Urabe, Montague, & Hearing, 1992). 
Tyrosinase is a bifunctional copper containing glycoprotein composed of 511 amino 
acids with a molecular mass of 60-70 kDa (Nishioka, 1978). The synthesis of tyr-ase occurs in 
the ribosome en route to the golgi complex, and is subsequently delivered to the melanosomes 
(V. J. Hearing & Ekel). Tyrosinase consists of an inner domain that resides inside the 
melanosome, a transmembrane domain and a cytoplasmic domain (Vincent J. Hearing & 
JimÉNez, 1989). The cytoplasmic domain facilitates tyr-ase transport from the ribosome to the 
golgi complex (Vijayasaradhi, Xu, Bouchard, & Houghton, 1995). 
1.1 Biosynthesis of catecholamine neurotransmitters 
The diphenol amino acid, L-dihydroxyphenylalanine (L-dopa) is a significant 
intermediate in the biological synthesis of three catecholaminergic neurotransmitters in neurons 
(Solano, et al., 1999). Dopa 2 is generated from tyrosine 1 by the action of tyr-ase. Dopamine, 3 
an essential neurotransmitter is formed by the metabolic breakdown of L-dopa in the presence of 
dopa β decarboxylase (DBH, Scheme 1.1). The deficiency of dopamine in the human brain leads 
to Parkinson’s disease. Norepinephrine, 4 is an important intermediate involved in the 
catecholamines biosynthesis and is formed by the action of DBH on dopamine (Scheme 1.1). 
Epinephrine 5, a catecholamine is formed by the action of phenol ethanolamine-N-methyl 
transferase (PMT) on norepinephrine (White, Handler, & Smith, 1964). 
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1.2 Biosynthetic pathway of melanin 
In melanogenesis, tyr-ase catalyzes the first two rate determining steps in the biological 
process (Scheme 1.2). The metabolic precursor of melanin, tyrosine is hydroxylated to form dopa 
(Furumura, Sakai, Abdel-Malek, Barsh, & Hearing, 1996). Subsequently, dopa oxidizes to form 
dopaquinone (DQ); which is then processed into either eumelanin or pheomelanin (Slominski, 
Zmijewski, & Pawelek, 2012).  
1.2.1 Pathway of eumelanogenesis. During eumelanogenesis in the presence of tyr-ase, 
the amino group of DQ undergoes an intramolecular 1, 4-addition to give rise to the 
leukodopachrome (Scheme 1.2, Park, et al., 2004). The rearrangement of leukodopachrome 
catalyzed by Trp 2 produces DHI as a major product and DHICA as a minor product 
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(Tsukamoto, et al., 1992). Finally, the dihydroxyindoles are oxidized to form eumelanin (Ito, 
2003). The velocity of the process depends on tyr-ase related proteins (Slominski, et al., 2012). 

















































1.2.2 Pathway of pheomelanogenesis. The pheomelanins are present in certain types of 
reddish hair and feathers. Pheomelanins usually occur together with biogenetically related 
trichochromes. The trichochromes are commonly found in feathers and red human hair. 
Trichochromes are of four types, B, C, E and F respectively. Trichochromes B and C are yellow 
to orange colored, and E and F trichochromes are violet. The basic structural unit of 
trichochromes consists of a 1, 4 benzothiazine ring system existing in 2H and 4H tautomeric 
forms.  
Pheomelanins are zwitterionic in nature, soluble in both dilute alkali and in certain acidic 
solvents. This character is due to the presence of alanine side chains that form the backbone of 
the pigment by attaching to the subunits. The general structure of pheomelanin is not clearly 
known. They appear to be irregular polymers or a mixture of polymers lacking well defined 
spectral and physical characteristics (Prota, 1992). 
During the process of pheomelanogenesis, the thiol group of cysteine covalently attaches 
to the DQ to form cysteinyl dopa (CD, Scheme 1.3). In the presence of tyr-ase, cysteine may 
covalently incorporate at the 2 or 5 ring positions of DQ although the 5-CD is favored as a key 
intermediate in the biosynthesis of pheomelanin (Prota, 1992). The compound, 5-CD may be 
involved in the oxidative ring closure of the cysteine side chain leading to the formation of an 
unstable o-quinone-imine intermediate in significantly less yields. The quinone intermediate may 
give rise to dihydrobenzothiazine or 1, 4 benzothiazine. The CD is oxidized to form the CD-
quinone, which upon cyclization leads to 1, 4 benzothiazine. The intermediate 1, 4 benzothiazine 




Scheme 1.3. John Simon’s pathway of pheomelanogenesis (Ito, 2003). 
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 1.3 Tyrosinase in the biosynthesis of melanin 
Melanin plays a crucial role in the absorption of free radicals generated within the 
cytoplasm and in protecting the human skin from the harmful effects of  solar UV radiation 
(Prota, 1992). The increased rate of tyrosine hydroxylation and dopa oxidation leads to increased 
melanin formation. Although melanin has a photo-protective function, the accumulation of 
abnormal melanin in the skin can cause hyperpigmentation disorders such as melanoma, freckles, 
melasma, ephelides, senile lentigo and age spots (Park, et al., 2004). Hence, the knowledge of 
melanocyte biology and the process underlying melanin synthesis had made remarkable progress 
over the few years (Prota, 1992). 
The major cause of melanoma results from exposure to ultraviolet (UV) radiation. There 
are three types of UV radiations. For example, UV-A represents wavelength ranging from 400 
nm to 315 nm, UV-B from 315 nm-280 nm and UV-C ranging from 100-200 nm. Of these 
radiations, UV-B is dangerous and directly damages the DNA; whereas UV-A targets cellular 
photo sensitizers (V. J. Hearing & Tsukamoto, 1991). 
The enzyme, tyr-ase contains three binding sites; which include two active sites and one 
allosteric site. The active sites are where chemical conversion take place and tyrosine and dopa 
bind. The L form of dopa not only binds to the active or the substrate site, but also to the 
allosteric or the cofactor site. Since L-dopa can bind at both sites, studies have shown that the 
addition of external L-dopa increases the levels of  tyrosine hydroxylation and L-dopa oxidation 
which subsequently leads to the enhancement of melanogenesis (Chang, 2009). As try-ase is an 
essential enzyme in the regulation of melanogenesis, this enzyme becomes a prime 
substrate/cofactor target for a variety of exogenous molecules in the regulation of melanogenesis 
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(Sander, Hamm, Elsner, & Thiele, 2003). There are three inhibitory mechanisms associated with 
the enzyme, tyr-ase. Of these inhibitory mechanisms, competitive inhibition is the process where 
the compound binds to the free enzyme and thus inhibits the binding of endogenous substrate to 
the enzyme. Non-competitive inhibition is the binding of compound to the enzyme-substrate 
complex and thus inhibiting the formation of melanin. A mixed type of inhibition is where the 


















2.1 Modified Erlenmeyer synthesis of dopa via azalactone 
Various methods are available for the synthesis of α-amino acids, as the amino acids can 
act as homologs of dopa to be utilized as therapeutic molecules in the regulation of 
melanogenesis. Casimir Funk developed a modified Erlenmeyer synthesis of dopa by protecting 
the catechol group (Scheme 2.1). The compound carbonyldihydroxybenzaldehyde, 6 was 
subjected to condensation with hippuric acid 7 to yield azalactone 8. The product, 8 was 
subjected to hydrolysis to give benzamido-3, 4-dihydroxycinnamic acid 9 which upon treating 
with hydrogen in the presence of a catalyst gave benzoyl-3, 4-dihydroxyphenylalanine 10. The 
final product, dopa 2, was obtained by refluxing 10 with aqueous hydrochloric acid (HCl) and 
then neutralizing with sodium hydroxide; NaOH (Funk, 1911). 





































2.2 Modified Erlenmeyer synthesis of dopa via vanillin 
The Erlenmeyer syntheses of the racemic mixture of dopa lead to valuable procedures in 
the synthesis of dopa and its homologs (Harington & Randall, 1931). Hirai synthesized racemic 
dopa by condensing vanillin 11 with acetic anhydride (Scheme 2.2). The acetic anhydride was 
used to condense the cyclic diamide 12 with aldehyde 11 to yield adduct 13 by replacing the 
hydroxyl group with O-acetyl group. The resulting mixture containing the adduct 13 was 
refluxed with concentrated HF in the presence of red phosphorus to give rise to dopa (Waser & 
Lewandowski, 1921). 
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2.3 Synthesis of d and l forms of dopa 
Stephen and Weizmann used an alternating method by utilizing alkylated sodio 
pthalimidomalonate with methylenedioxybenzylbromide to synthesize a racemic mixture of dopa 
(Stephen & Weizmann, 1914). In 1913, Guggenheim was the first to isolate L-dopa from a plant 
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called Vicia faba (Harington & Randall, 1931).In 1931, Harrington and Randall synthesized d 
and l forms of dopa separately from dl-β-3, 4-diacetoxyphenyl-α-acetaminoacrylic acid, 11 
(Scheme 2.3). Reduction of compound 14 with sodium amalgam gave dl-β-3, 4-diacetoxyphenyl-
α-acetaminopropionic acid 15. The resulting product, 15 was treated with one equivalent of 
hydrated brucine (alkaloid) in concentrated alcohol; which resulted in crystallization. The 
crystallized species, the salt of brucine l-β-3, 4-dihydroxyphenyl-α-acetaminopropionate 17 was 
separated, and the filtrate was concentrated under reduced pressure to yield brucine d-β-3, 4-
dihydroxyphenyl-α-acetaminopropionate 16. The resulting products 17 and 16, were hydrolyzed 
with hydrochloric acid to give d-dopa and l-dopa  respectively (Harington & Randall, 1931). 



















































d-dopa l-dopa  
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2.4 Synthesis of dopa via α oxamino acid 
Throughout the nineteenth century, a host of methods have been developed and applied 
toward the synthesis of dl-dopa (Stephen & Weizmann, 1914). Hamlin proved that α-amino acids 
can be prepared by the reduction of α-oxamino acids (Barry, Mattocks, & Hartung, 1948). In 
1948, Richard et. al were quite successful in  synthesizing a variety of intermediates enroute to 
the production of dopa (Scheme 2.4). These intermediates consist of α-oxamino acids from 
acetoacetic and malonic esters. The nitrosation reaction of 3, 4-methylenedioxybenzyl malonic 
acid 18 with alkyl nitrite in the presence of HCl gave α-oxamino-β-(3, 4-methylenedioxyphenyl)- 
propionic acid 19. The catalytic reduction of 19 with HCl yielded 3, 4-methylendioxy 
phenylalanine 20, a very stable product. The product 20, can be hydrolyzed with HI to yield dopa 
(Barry, et al., 1948).    
Scheme 2.4. Richard’s synthesis of dopa using malonic acid (Barry, et al., 1948).      



























2.5 Synthesis of dopa by asymmetric dihydroxylation 
There has been a variety of selective methods developed for the synthesis of dopa. An 
important method involved asymmetric dihydroxylation (AD) reaction of olefins (Kolb, 
VanNieuwenhze, & Sharpless, 1994). In 2004, Iliyas synthesized dopa using an AD reaction 
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involving reductive ring opening of aziridines (Scheme 2.5). Styrene (21) was subjected to the 
AD reaction in the presence of a catalytic amount of osmium tetraoxide (OsO4) and 
hydroquinine-1, 4-pthalazinediyldiether to give vicinal diol 22. Thionyl chloride (SOCl2) and 
methylene chloride were added to 22 in the presence of triethylamine and dichloromethane at 
0
o
C to yield cyclic sulfite 23, which upon treating with sodium azide gave azido alcohol 24. 
Triphenylphosphine (PPh3) in acetonitrile was added to 24 to give 3-phenylaziridine-2-
carboxylic ester 25, which was then, treated with ammonium formate and 10% palladium to give 
amine 26. The amine, 26 was subjected to hydrolysis with 6M HCl to obtain l-dopa (Sayyed & 
Sudalai, 2004). 















































2.6 Synthesis of α amino acid by hydrolysis 
Since the 50’s, a wide variety of methods have been developed for the synthesis of α-
amino acids. Dennis and Sutherland developed a convenient amino acid synthesis which 
employed 2-amino-2-(cyclopent-2-enyl) acetic acid 30 as a glycine equivalent (Scheme 2.6). 
This method has shown that the 3-chlorocyclopentene 27 is formed from cyclopentadiene and 
hydrogen chloride. The condensation of 27 with diethyl acetamidomalonate (DEAM), 28 
resulted in the formation of the diethyl acetamido-2-cyclopentene-1-malonate 29. The glycine 
equivalent, 30 was obtained upon hydrolysis and decarboxylation of 29 in the presence of 10% 
HCl (Dennis, Plant, Skinner, Sutherland, & Shive, 1955). 






















2.7 Synthesis of α amino acid by stereoselective enolate alkylation 
Williams et. al have developed and applied asymmetric syntheses towards the 
construction of non-proteinogenic α-amino acids by employing nucleophilic and electrophilic 
bond formations in diphenyloxazinones (Williams & Im, 1991). William’s method involved the 
reactions of D and L erythro forms of oxazinone 31a and 31b with sodium and lithium 
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bis(trimethylsilyl)amide in THF and methyl iodide to yield monoalkylated oxazinone 32a and 
32b respectively (Scheme 2.7). The boc protected amide, 32a was first treated in 
dichloromethane with trifloroacetic acid, and subsequently in the presence of palladium to yield 
L-amino acid 33a. A similar method was applied in the synthesis of the isomeric form of 33b, 
with the exceptions as shown in Scheme 2.7. The methyl-glycine products formed through 
nucleophilic carbanion alkylation were isolated in 95% enantiomeric excess. The anionic form of 
the same methyl-glycine product can undergo a second alkylation reaction; thus resulting in a 
dialkylated product. 

















































2.8 Synthesis of fluorescent amino acid by hydrolysis 
Guodong et. al developed a synthetic method for producing racemic coumarin based 
florescent amino acid, DL-2-amino-3-(6, 7-dimethoxy-4-coumaryl)-propionic acid (DL-Adp, 
Scheme 2.8). The sodio anion of DEAM was alkylated with the flourogenic broup 4-(bromo 
methyl)-6, 7 dimethoxycoumarin 34 to give 2-acetylamino-2-(6, 7-dimethyoxy-4-coumaryl 
methyl)-malonic acid diethyl ester 35 (Sui, Kele, Orbulescu, Huo, & Leblanc, 2001). The 
resulting diethyl ester (35) was hydrolyzed with 6N HCl to form racemic DL- Adp.  



















2.9 Statement of problem 
The main objective of this work is to synthetically structure dopa mimetics (homologs 
and analogs) in order to regulate the process of melanogenesis by altering the activity of the 
enzyme, tyr-ase. These dopa mimetics may be structured as analogs or homologs. The ideal 
homolog differs from an analog by one carbon unit. A variety of structural designs of the dopa 
mimetics are proposed to prevent or slow down the process of melanogenesis; by acting as 
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competitive inhibitors. The dopa mimicking features of the homologs involve strategic synthetic 
designs of the molecular framework of the homologs that give rise to similar or identical 
dimensions as that of dopa. In addition to optimizing the dopa mimicking features, this work has 
led to the development of a variety of strategies in regulating tyr-ase. The validation of the 
structuring methods will be verifying based on their regulatory activity towards tyr-ase. In this 
work several dopa homologs were proposed (Figure 1.1). Out of the compounds proposed, three 














































3.1 Synthesis of 2-bromo-3, 4-dimethoxy acetophenone (38) 
This reaction required the use of a reflux apparatus that was connected to a dropping 
funnel and a calcium chloride tube. To a stirring and refluxing solution of 62.40 g (94 mmol) 
copper II bromide (CuBr2) in 225 ml of ethyl acetate was added 30.00g (56 mmol) of 3, 4-
dimethoxy acetophenone (56 mmol) through a dropping funnel for 10 mins. The resulting 
greenish color solution was refluxed for 7hrs after which CuBr2 (21.00 g, 31.65 mmol) was 
added. The resulting mixture was allowed to continue reflux overnight with stirring. The dark 
purple solution was cooled to room temperature and was vacuum filtered to get rid of the copper 
salts. The filtrate was concentrated using a rotary evaporator. The resulting product was 
completely dried under reduced pressure to form a solid of 38.   
For recrystallization, the product 38 (2.00 g) was dissolved in methanol (~ 9ml) and 
stirred until dissolved at room temperature for 10 mins resulting in a brown solution. Upon 
cooling, crystals were formed; which were vacuum filtered. For further purification, the 




H NMR (CDCl3) δ 3.95 (s, 3H), 3.98 (s, 3H), 4.43 





), 165;  IR (KBr) 3090, 3050, 2991, 2850, 1681, 1585, 1513, 1419, 1275, 
1244, 1146, 1020, 619. 
3.2 Synthesis of diethyl 2-acetamido-2-(2-(3, 4- dimethoxy phenyl)acetyl)malonate (39) 
The reaction apparatus was set up for reflux in an oil bath under an atmosphere of 
nitrogen at 70
0
C. Sodium hydride dispersed in 60% of mineral oil (2.27 g and 56.5 mmol) was 
washed with hexane to remove the mineral oil. The hexane was decanted and was neutralized 
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with anhydrous isopropanol. The activated sodium hydride was immediately added to the 
reaction flask. Residue of sodium hydride left in the beaker was rinsed with DMSO (81.6 ml) 
and added to the reaction flask. Solid anhydrous DEAM (8.47 g, 39 mmol) was added to the 
solution resulting in the liberation of hydrogen gas. The resulting reaction mixture was stirred at 
70
0
C for 3 hrs producing a yellowish solution. The bromo-ketone, 38 (10.00 g, 39 mmol) 
dissolved in 81.6 ml of toluene was added to the reaction flask using a dropping funnel, and the 




The resulting dark brown reaction mixture was cooled, and distilled water (150mL) was 
added to the reaction flask. The resulting mixture was added to a separatory funnel, and the 
organic layer (product) was separated.  The aqueous layer was extracted three additional times 
with 60 ml portions of ethyl ether, and the organic extracts were combined and washed twice 
with 60 ml of distilled water and washed once with 60 ml of saturated sodium chloride. The 
organic layer was simultaneously dried and decolorized with anhydrous sodium sulfate and with 
activated carbon. The resulting mixture was filtered and concentrated using a rotary evaporator 
to yield crude brown crystals (87%). The crystals can be further purified by recrystallization 




H NMR (CDCl3) δ 1.25 (t, 6H, J=7.6 Hz), 
2.0 (s, 3H), 3.85; 3.95 (s, 3H; s, 3H), 4.25 (s, 2H), 4.32 (q, 4H, J=7.6 Hz), 6.88; 7.5; 7.63 (d, 1H, 
J=9.0 Hz; s, 1H, D, 1H), 7.25 (s, 1H); MS, m/z 395 (M
+
), base peak 165; IR (KBr) 3344, 300, 
2938, 2847, 1750, 1740, 1666, 1657, 1596, 1517, 1420, 1290, 1213, 1023. 
3.3 Synthesis of 2-amino-4-(3, 4-dimethoxy phenyl)-3-oxobutanoic acid (40) 
  The reaction apparatus was set up for reflux under an atmosphere of nitrogen. The 
product 39 (15.00 g) was grinded using a mortar and pestle for easy dissolution. The pulverized 
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crystals were added into a round bottom flask and concentrated hydrochloric acid was added 
(112 ml). The reaction mixture was allowed to stir vigorously at room temperature for 30 min 
under an atmosphere of nitrogen. An equal volume of distilled water (112 ml) was added to 
dilute the acidic reaction mixture to give rise to a 50% hydrochloric acid mixture. The resulting 
reaction mixture was refluxed overnight. The dark brown solution was concentrated under 
reduced pressure to yield 40. Isopropyl alcohol was added to the product 40b with stirring until 
completely dissolved. Activated charcoal was added to the solution with stirring. The resulting 
mixture was vacuum filtered (i.e., 1X-2X) as needed, and subsequently concentrated to yield a 
dark brown/reddish solid.  Using a reflux set-up, 70 ml ethyl acetate was added to the solid 
which was then stirred vigorously under reflux for 15 mins. The mixture was cooled, and the 
undissolved (product) crystals were vacuum filtered. This procedure was repeated a second time, 
and the filtered solid was concentrated to complete dryness under reduced pressure to give rise to 
a dark purple solid (45%). The filtrates can be saved, combined with future filtrates and 
concentrated for further use; 
1
H NMR 3.64 (dd, 2H, J=20.1, 5.8 Hz), 3.80; 3.82 (s, 3H; s, 3H), 
4.24 (q, 1H, J=4.9 Hz), 7.03 (m, 2H), 7.44 (ddd, 3H), 7.64 (d, 1H, J=8.4 Hz), 9.57 (s, 1H). 
3.4 Synthesis of 2-bromo-6-methoxy tetralone (42)  
This reaction required the use of a reflux apparatus connected to a dropping funnel and a 
calcium chloride tube. To an appropriate sized reaction flask was added, copper II bromide 
(25.50 g, 87.6 mmol) and 90 ml ethyl acetate. The stirred solution was allowed to come to reflux, 
and through a dropping funnel over a period of 10-15 mins was added, 6- methoxy tetralone 41 
(12.00 g, 18.6 mol) dissolved in 120 ml of chloroform. The resulting mixture was refluxed for 8 
hrs after which time was added a second portion of CuBr2 (8.52 g). The resulting mixture was 
allowed to continue refluxing overnight with stirring. The dark purple resulting mixture was 
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cooled to room temperature and was vacuum filtered to get rid of the copper salts. If necessary, 
the filtrate can be filtered a second time in order to completely remove the copper salts. The 
yellow filtrate was concentrated from solvent using a rotary evaporator to yield the crude brown 
colored brominated product (42). The crude brominated product was completely concentrated 
using reduced pressure. 
For recrystallization, methanol (7.6 ml) was added to 42 (2.00 g) at room temperature 
with stirring until the solid product dissolved. The resulting solution was cooled on ice to give 
rise to product crystals. The solution was vacuum filtered, and concentrated under reduced 
pressure in order to isolate product crystals of 42  (92.6%), 
1
H NMR (CDCl3) δ 2.16 (dt, 1H), 
2.46 (m, 1H), 2.86 (dt, 1H, J=17.1, 4.5 Hz), 3.27 (dt, 1H, J= 15.8, 5.1 Hz), 4.68 (t, 1H, J=4.3 





3.5 Synthesis of diethyl 2-amino-2-(1, 2, 3, 4-tetrahydro-6-methoxy-1-oxonaphthalen-2-
yl)malonate (43) 
The reaction apparatus was set up for reflux in an oil bath and under an atmosphere of 
nitrogen at 70
0
C. Sodium hydride dispersed in 60% mineral oil (1.40 g, 34.2 mmol) was washed 
with hexane to remove the mineral oil. The hexane was decanted and was cautiously neutralized 
with anhydrous isopropanol. The activated sodium hydride residue was immediately added to the 
reaction flask. Residue of sodium hydride left in the beaker was rinsed with DMSO (49.3 ml) 
and added to the reaction flask. Solid anhydrous DEAM (5.23g, 24.1 mmol) was added to the 
solution resulting in the liberation of hydrogen gas. The resulting reaction mixture was stirred at 
70
0
C for 3 hrs producing a yellowish solution. The bromo-ketone, 42 (5.00 g, 19.69 mmol) 
dissolved in 49.3 ml of toluene was added to the reaction flask using a dropping funnel, and the 





C. The resulting dark brown reaction mixture was cooled, and distilled water (150 ml) was 
added to the reaction flask. The resulting mixture was added to a separatory funnel, and the 
organic layer (product) was separated. The aqueous layer was extracted three additional times 
with 60 ml portions of ethyl ether, and the organic extracts were combined, washed twice with 
60 ml of distilled water and washed once with 60 ml of saturated sodium chloride. The organic 
layer was simultaneously dried and decolorized with anhydrous sodium sulfate and with 
activated carbon. The resulting mixture was filtered and concentrated using a rotary evaporator 
to yield crude brown product crystals of 43 (76.4%). The crystals can be further purified using 
either, ethyl acetate/petroleum ether or methanol/hexane. 
1
H NMR δ 1.24 (t, 6H), 1.88; 1.92 (m, 
2H), 2.0 (s, 3H), 2.9 (dt, 1H), 3.15 (dt, 1H), 3.83 (s, 3H), 4.26 (tt, 4H, J=17.9, 10.7), 6.76 (m, 
2H), 6.91 (d, 1H, J=6.2 Hz), 7.90 (d, 1H, J=8.8 Hz); MS m/z 391 (M
+
), 175.  
3.6 Synthesis of 2-amino-2-(1, 2, 3, 4-tetrahydro-6-hydroxy-1-oxonaphthalen-2-yl)acetic 
acid (44) 
The reaction apparatus was set up for reflux under an atmosphere of nitrogen. The diester 
amide of tetralone 43 (4.00 g) was grinded using a mortar and pestle for easy dissolution. The 
pulverized crystals were added into a round bottom flask and concentrated hydrobromic acid was 
added (60 ml). The reaction mixture was allowed to stir overnight under an atmosphere of 
nitrogen. The resulting dark brown mixture was concentrated under reduced pressure to yield 44. 
Isopropyl alcohol was added to the product 44 with stirring until completely dissolved.  
Activated charcoal was added to the solution with stirring. The resulting mixture was vacuum 
filtered (i.e., 1X-2X) as needed, and the filtrate was subsequently concentrated to yield a dark 
purple solid.  Using a reflux set-up, 25-30 ml ethyl acetate was added to the solid which was then 
stirred vigorously under reflux for 15 mins. The mixture was cooled, and the un-dissolved 
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product crystals were vacuum filtered from the filtrate. This procedure was repeated a second 
time, and the resulting solid was concentrated completely from residual solvents under reduced 
pressure to give rise to a dark purple solid (60%). 
1
H NMR (DMSO) δ 1.91; 2.14 (t, 2H), 2.85; 
3.0 (t, 2H), 3.25-3.68 (t, 1H), 4.39 (s, 1H), 4.42 (s, 1H), 6.61; 6.71 (s, 2H), 6.96; 7.13; 7.30 (d, 
3H), 7.76 (t, 1H, J=8.0 Hz), 10.49(s, 1H). 
3.7 Synthesis of 2-amino-2-(1, 2, 3, 4-tetrahydro-6-methoxy-1-oxonaphthalen-2-yl)acetic 
acid (45) 
The same method developed for the synthesis of compound 40 was also used in the 
synthesis of 6-methoxy tetralone amino acid, 45. The resulting solid was concentrated 
completely from solvents under reduced pressure to give rise to a light brown colored solid. 
1
H 
NMR (DMSO) δ 2.02; 2.23 (td, 2H), 3.01; 3.65 (d, 2H, J=16.6 Hz), 3.82 (s, 1H), 4.41 (t, 1H, J= 
7.5 Hz), 6.72 (d, 1H), 6.90 (t, 1H, J= 10.0, 4.7, 3.5), 712; 7.29; 7.46 (d, 3H), 7.80 (dd, 1H, J=8.6, 
6.1), 10.62 (s, 1H).  
3.8 Synthesis of 2-bromo-5-methoxy indanone (47)  
This reaction required the use of a reflux apparatus connected to a dropping funnel and a 
calcium chloride tube. To an appropriate sized reaction flask was added, CuBr2 (13.30 g, 59.54 
mmol) and 44 ml ethyl acetate. The stirred solution was allowed to come to reflux, and through a 
dropping funnel over a period of 10-15 mins was added, 5-methoxy indanone, 47 (5.75 g, 35.71 
mmol) dissolved in 63 ml of chloroform. The resulting mixture was refluxed for 8 hrs after 
which time was added a second portion of CuBr2 (4.43 g, 19.83 mmol). The resulting mixture 
was allowed to continue refluxing overnight with stirring. The yellow resulting mixture was 
cooled to room temperature and the copper salts were vacuum filtered to give rise to a reddish 
brown product solution. The resulting filtrate was concentrated using a rotary evaporator to yield 
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the crude brominated product 47. The crude brominated product was completely concentrated 
using reduced pressure. The resulting product was recrystallized by the same method used for 42. 
The resulting solution was vacuum filtered, and concentrated under reduced pressure in order to 
isolate product crystals of 47. 
1
H NMR (CDCl3) δ 3.37 (d, 1H, J=1801 Hz), 3.78 (d, 1H), 3.91 (s, 






3.9 Synthesis of diethyl 2-acetamido-2-(2, 3-dihydro-5-methoxy-1-oxo-1H-inden-2-
yl)malonate (48) 
The same method developed for the synthesis of compound 43 was also used in the 
synthesis of compound 48. The reaction apparatus was set up for the reflux in an oil bath under 
an atmosphere of nitrogen at 70
0
C. Sodium hydride (1.76 g, 44 mmol) dispersed in 60% mineral 
oil was washed with hexane to remove the mineral oil. The hexane was decanted and was 
cautiously neutralized with anhydrous isopropanol. Residue of sodium hydride left in the beaker 
was rinsed with DMSO (63.5 ml) and added to the reaction flask. Solid anhydrous DEAM (6.52 
g, 30 mmol) was added to the solution resulting in the liberation of hydrogen gas. The resulting 
reaction mixture was stirred at 70
0
C for 3 hrs producing a yellowish solution. The bromo-ketone, 
47 (6.00 g, 30 mmol) dissolved in 63.5 ml of toluene was added to the reaction mixture and was 
refluxed overnight under an atmosphere of nitrogen at 70
0
C. The resulting reaction mixture was 
cooled and extracted by the same method of extraction used for product 43. The resulting 
reaction mixture was filtered and concentrated using a rotary evaporator to yield crude orange 




C NMR (CDCl3) δ 13.9 (-OCH3), 23.16 
(-CH3), 55.6 (-CH2), 62.6 (-CH), 62.9 (-OCH3), 66.1 (-CH2), 111.5 (-CH), 129.7 (-CH), 147 (-




Results and Discussion 
The overall strategies employed in the synthesis of dopa homologs involved the strategic 
synthetic construction of compounds that highly mimic the structure of dopa, and when these 
same compounds are acted upon by the enzyme tyr-ase, they are subsequently able to utilize 
incorporated structural features that favorably regulate the process of melanogenesis. It is also 
expected that the intrinsic binding strength and the regulatory ability of the proposed substrates 
will be most influential towards the enzyme, tyr-ase when compared to the endogenous 
substrates.  
4.1 Expected mechanism of action of dopa homologs 
The structural designs of the dopa mimetics are likely to exhibit inhibitory activity on 
melanin formation within malignant melanocytes. Once the dopa homolog has displayed activity 
within the active site of tyr-ase, this would suggest that the C-4 framework of the homolog has 
not exceeded the binding domains of the active site of the enzyme. Once the binding domain for 
try-ase is established, the exogenous amino acids are expected to utilize their structured features 
to inhibit melanin formation. 
4.1.1 Amino cyclization prevention. Amino cyclization prevention is a feature 
synthetically incorporated into the structural frame-work of the dopa homologs that inhibits the 
formation of melanin (Scheme 4.1). In this strategy, an inert group is incorporated at the 2-
position of the 3, 4-dopaquinone which prevents the nucleophilic attack of the lone pair of 
electrons on nitrogen; which subsequently prevents the formation of the requisite intermediate 
























4.1.2 Chelation functionalization. Chelation functionalization is another strategy used 
for inhibiting melanogenesis (Scheme 4.2). It occurs by incorporating functional groups within 
the molecular framework of relevant molecules that can bind at the copper active site of tyr-ase. 
The lone pair of electrons on hetero atoms are prime candidates in chelating with copper at the 
active site of tyr-ase. This results in the inhibition of the endogenous dopa binding to the active 
site of tyr-ase, thus preventing the formation of melanin. 





















4.1.3 Polarized functionalization. Polarized functionalization was a method developed 
for the inhibition of melanogenesis (Scheme 4.3). In this methodology, a polar group is 
incorporated at the 2-position of the 3, 4-Dopaquinone. The polarized group undergoes 
nucleophilic attack to give rise to equilibrium between the precursory DQ and the intermediate 
which inhibits melanin production and therefore, inhibits phase II of melanogenesis. The 
exogenous DQ as displayed below in Scheme 4.3, can undergo two modes of futile attack, at the 
2-aromatic position or at the carbonyl carbon of the 2-aromatic position respectively. 




































4.2 2-amino-4-(3, 4-dimethoxyphenyl)-3-oxobutanoic acid (40) 
The synthesis of 2-amino-4-(3, 4dimethoxyphenyl)-3-oxobutanoic acid 40 involved the 
utility of 3, 4 dimethoxy acetophenone 37 (Scheme 4.4). The bromo ketone 38 was condensed 
with DEAM to give rise to the keto diester amide 39, which was then subsequently hydrolyzed to 
form the glycine equivalent, 40.  
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4.2.1 2-bromo-3, 4-dimethoxy acetophenone (38). A considerable effort was made to 
develop an efficient and inexpensive synthetic route to produce α- bromo ketones by employing 
different brominating agents. In the process of obtaining a brominating agent, we attempted to 
use pyridinium tribromide as a brominating agent. This method did not yield the desired product 
in a sizable yield based on GC/MS analysis (Siegel & Graefe, 1953). In response to the inability 
to produce a significant amount of bromo ketone, an alternative brominating method was used 
involving copper (2) bromide; CuBr2 (Scheme 4.4). This procedure involved two separate 
addition of CuBr2, in which the initial duration continued for 3 hrs and the second duration was 
for 4 hrs (King & Ostrum, 1964). The chromatogram of the GC/MS of the resulting product gave 
an indication of an abundant amount of starting material. The most effective procedure involved 
reacting 37 with the first portion of CuBr2 for 14 hrs and then the second portion for 8 hours to 
give 92.6% yield of the expected product (Figure 4.1). The brominated product obtained was 
identified and evaluated using GC/MS, FTIR and proton NMR analyses.  
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The gas chromatogram as featured in Figure 4.1 displays peaks for the starting material 
(13.21min), the bromoketone 38 (15.89 min) and the di-bromoketone  (18.51 min). The synthesis 
using CuBr2 gave rise to an abundance of the bromoketone, 38 (15.89 min) as displayed by the 
GC-MS (Figure 4.1-4.2). The mass spectrum reveals the base peak of 38 at 165 (m/z) and 
molecular ion peak at 258 (Figure 4.2). The occurrence of the base peak of bromo ketone 38 is 
indicative of α-cleavage of methylene bromo moiety to give rise to its respective acylium cation. 
The synthesis of bromo ketone 38 with CuBr2 was determined to be the method of choice, due to 
its purity and percentage yield. 
              
Figure 4.1. Gas chromatogram of 2-bromo-3, 4-dimethoxy acetophenone. 

















































Figure 4.2. Mass spectrum of 2-bromo-3, 4-dimethoxy acetophenone. 
4.2.2 2-chloro-3, 4-dimethoxy acetophenone. The GC/MS for the chloro ketone is 
shown in Figures 4.3 and 4.4. The method developed for the synthesis of chloroketone, 
employed sulfuryl chloride as the chlorinating agent. The GC analysis indicated the starting 
material as a major component at 13.38 min and the product peak as being a minor component at 
14.62 min. The mass spectrum indicates the molecular ion peak at 214 (M
+
) and 216 (M+2) with 
intensity ratios of 3:1 respectively, which represents the monochlorinated product. 
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Figure 4.3. Gas chromatogram of 2-chloro-3, 4-dimethoxy acetophenone. 





























Figure 4.4. Mass spectrum of 2-chloro-3, 4-dimethoxy acetophenone. 
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4.2.3 Diethyl 2-acetamido-2-(2-(3, 4-dimethoxy phenyl)acetyl)malonate (39). With 
respect to the keto diester amide 39, the synthetic method is shown in Scheme 4.4 on page 30. 
The bromoketone was condensed with the sodio anion of DEAM, which was generated in a 
refluxing medium consisting of anhydrous sodium hydride (NaH) in a 50:50 solvent mixture of 
DMSO and toluene to give the diester amide, 39 (King & Ostrum, 1964).  
The produced yields of the diester amide were compared using 1.05 eq and 1.15 eq of 
sodium hydride. This reaction was most efficient using 1.15 eq of NaH. The keto diester amide 
39 is expected to be the most important intermediate regarding the dopa homolog because of its 
versatile functionality.   
The 
1
H NMR of product 39 indicated chemical shifts consistent with the expected 
compound. Evaluation of product 39 utilizing GC/MS gave a variety of fragmentation ions when 
a gradient temperature profile was used. There were two major peaks displayed in the GC, 
indicating the starting material and the expected product. A second method was used to analyze 
the keto diester amide 39 by running the sample isothermally, due to its thermolability. The 
resulting GC displayed peak was indicative of product 39 (Figure 4.5). The mass spectrum of 
compound 39 indicated the molecular ion peak at 395 m/z (Figure 4.6). The second most 
abundant peak in the mass spectrum is indicative of compound 39 undergoing demethylation. 
The base peak indicates keto α cleavage and formation of the respective acylium ion. In 
summary, the synthetic route using 1.15 eq of NaH was determined to be the method of choice; 






  Figure 4.5. Gas chromatogram of diester amide of acetophenone. 
































 Figure 4.6. Mass spectrum of diester amide of acetophenone. 

































4.2.4 2-amino-4-(3, 4-dimethoxy phenyl)-3-oxobutanoic acid (40). Several methods 
were employed in the synthesis of the dopa homolog, 40. These methods involved the acid 
hydrolysis and decarboxylation reactions of 39 using two different acid concentrations in 
isolating either the amine or the ammonium salt. In utilizing 25% HCl refluxed for 8 hrs, the 
product was basified with ammonium hydroxide to an isoelectric point of 5.6 (Herr, Enkoji, & 
Dailey, 1957). Uncommonly, the expected neutral amine product did not precipitate at its 
isoelectric point.  
The experience gained in the acid-base hydrolysis, suggested a different methodology. 
The second method was carried out using 33% HCl (Dennis, et al., 1955). The resulting solution 
was concentrated to dryness, an appropriate amount of distilled water was added, and the 
aqueous layer was washed with ethyl acetate. The resulting aqueous wash was concentrated to 
give rise to the ammonium salt. The overall procedure for acid hydrolysis was carried out by 
adding the required amount of concentrated hydrochloric chloric acid to most effectively 
dissolve the keto diester amide. The desired concentration of hydrolysis was established by 
adding the appropriate amount of distilled water. Various final percentages of HCl (i.e, 30%, 
50%) were evaluated and it was determined that 50% HCl was most effective in giving rise to 
the highest percentage yield. 
 In evaluating the acid hydrolysis using 50% HCl, the 
1
H NMR spectrum was consistent 
in the characterization of the dopa homolog, 40 (Figure 4.7).  The peak at δ 9.57 indicates the 
presence of the hydroxyl proton of the carboxylic acid and the peaks at δ 7.36, 7.44 and 7.64 
indicate the protons of aromatic ring. The dimethoxy protons resonated at δ 3.79 and 3.82.  The - 
NH3Cl-CH proton-proton coupling give rise to three doublets for the NH3Cl moiety which 
39 
 
overlaps the aromatic protons at δ between 7-7.5 ppm. The broad peak at δ 8.40 represents the 
waters of hydration. 
 
 Figure 4.7. Proton NMR spectrum of amino acid of 3, 4-dimethoxy acetophenone. 
The keto moiety of dopa homolog 40 is a prime functionality in promoting side chain 
chelation at the copper active site of the enzyme, tyr-ase (Scheme 4.2, page 30). Thus, the keto 
function and the amino acid moiety are expected to bind copper at the active site of tyr-ase and 
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exclude the substrate conversion of endogenous dopa (Kahn & Andrawis, 1985). This type of 
exogenous chelation binding is capable of exhibiting significant inhibition of melanogenesis. The 
extended C-4 side chain homolog 40 may also act as a competitive substrate, and upon 
enzymatic conversion give rise to lower order oligomers rather than higher order melanin 
polymers, this activity is melanogenic inhibitory. Alternatively, the enzymatically converted side 
chain homolog 40 may give rise to a proportion of C-4 amino units incorporated into the 
resultant melanin(s) that give rise to a less destructive form of melanin as compared to the 
harmful form of rapidly produced C-3 melanins.   
4.3 Homologs of 6-hydroxy (44) and 6-methoxy tetralone (45) 
The synthesis of the tetralone homolog of dopa (44) is shown in Scheme 4.5. This 
synthetic route allows for the efficient synthetic entry to the equivalent methoxy dopa homolog, 
45. The first step in the synthesis of amino acids 44 and 45 involved the universal -bromination 
reaction applied to 6-methoxy tetralone (41) by employing CuBr2 to give rise to 42. The 
transformation of the remaining intermediates in route to the respective amino acids employed 
the same method used to synthesize dopa homolog 38 (Scheme 4.4). The cyclohexyl frame-work 
incorporated into the structures of dopa homologs 44 and 45 may give an indication of its 
molecular contracting influence as an effective means of enhancing the dopa mimicking abilities 
of 44 and 45. Thus, the cyclohexyl ring represents a C-4 side chain unit that can be compared in 
molecular length to the C-3 side chain of dopa. The methylene carbon of the cyclohexyl unit at 
the 2-position of aromatic rings of 44 and 45 prevents amino cyclization in forming 
leukodopachrome; as 44 and 45 will be evaluated for their aminocyclization inhibitory influence 
on melanogenesis (Scheme 4.1). As aforementioned, the keto-amino acid side chains of 44 and 
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45 are expected to act in an inhibitory manner by chelating at the Cu
+2
 active site of the enzyme, 
tyr-ase (Kahn & Andrawis, 1985). 




































4.3.1 2-bromo-6-methoxy tetralone (42). The GC/MS and 
1
H NMR spectra were 
consistent in the characterization of 42 (Figure 4.8). The gas chromatogram revealed the 
expected product peak at 20.98min and the less abundant peak for starting material at 17.23min.  
The mass spectrum displays the isotopic molecular ion peaks at 254 (M
+
) and 256 (M+2); which 
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confirms the monobrominated ketone, 42 (Figure 4.9). The base peak at 148 represents -keto 
cleavage which gives rise to the respective acylium cation. Gas chromatography–mass 
spectrometry analysis of the -bromo ketone 42 gave validation to the effectiveness of the -
bromination method employing CuBr2; as this method was used in all subsequent syntheses 
involving -bromination of ketones. 
 
Figure 4.8. Gas chromatogram of bromo tetralone. 




























Figure 4.9. Mass spectrum of bromo tetralone. 
4.3.2 Keto-diester amide of tetralone (43). The keto-diesteramide of tetralone 43 was 
synthesized by applying the same method used in the synthesis of 39 (Scheme 4.5). The GC/MS 
and 
1
H NMR spectra were consistent in the characterization of the keto-diesteramide, 43. The 
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GC/MS of the keto-diesteramide 43 was run isothermally to give rise to a single chromatogram 
peak at 11.64 min (Figure 4.10). The sample was run isothermally in order to preserve the 
molecular ion and therefore the appearance of the corresponding peak at m/z 391 (Figure 4.11). 
The mass spectrum revealed the base peak at m/z 175 which resulted from the loss of the diethyl 
acetamido malonate moiety group. The 
1
H NMR spectrum was also consistent with the desired 
product, 43. 
 
Figure 4.10. Gas chromatogram of diester amide of tetralone. 





























Figure 4.11. Mass spectrum of diester amide of tetralone. 
4.3.3 6-hydroxy tetralone homolog of dopa (44). Synthesis of the tetralone homolog of 
dopa involved complete deprotection and decarboxylation using 50% hydrobromic acid (HBr) to 
give rise to 60% yield of the desired product, 44. The resulting product 44 was confirmed using 
NMR analysis (Figure 4.12). The peak at δ 10.49 (s, 1H) represents the carboxyl proton, the peak 
at δ 4.39 represents the -proton of the chiral carbon, and the phenolic proton associates with 





































external water, resonates at δ 4.41. External  hydrogen bonding (i.e., exchange) with the NH3Br 
protons generally give rise to a peak near a δ of 7; whereas internal molecular association of the 
NH3Br protons allow for effective CH-NH proton-proton coupling to give rise to the 3 doublets 
at δ 6.96, 7.13 and 7.30.  (Donald L. Pavia, 2001). The singlet at δ 8.25 normally represents 
internal waters as hydrates. 
 
Figure 4.12. Proton NMR spectrum of 6-hydroxy tetralone amino acid. 
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4.3.4 6-methoxy tetralone homolog of dopa (45). Synthesis of the methoxy-tetralone 
homolog of dopa involved partial deprotection and decarboxylation using 50% hydrochloric acid 
(HCl) to give rise to 64% yield of the desired product 45. The resulting product 45 was 
confirmed using NMR analysis (Figure 4.13). The peak at δ 3.82 represents the uncleaved -
OCH3 group on the aromatic ring. The peak at δ 10.49 (s, 1H) represents the carboxyl proton and 
the resonance peaks at δ 6.72, 6.90 and 7.80 represent the aromatic protons. The peaks at δ 7.12, 
7.29 and 7.46 represent effective CH-NH proton-proton coupling.  
 
Figure 4.13. Proton NMR spectrum of 6-methoxy tetralone amino acid. 
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4.4 2-amino-2-(2, 3-dihydro-5-hydroxy-1-oxo-1H-inden-2-yl)acetic acid (49) 
The keto-dopa homolog 49 is structured to exhibit dopa mimicking features as well as 
melanogenic inhibition via preventive amino cyclization. The multi step synthesis of this 
compound is described in Figure 4.19. The overall method used in the synthesis of 49 is identical 
to the method used in the production of 44 (Scheme 4.6). 

























4.4.1 2-bromo-5-methoxy indanone (47). The mass spectrum/NMR is consistent in the 
characterization of -bromo ketone, 47. The gas chromatogram analyses suggest minor starting 
material and little evidence of the di-bromonated product. The GC peak for the expected bromo 
ketone is displayed at 15.16 min (Figure 4.14). The mass spectrum displays the isotopic 
molecular ion peaks at 240 (M
+
) and 242 (M+2); which confirms monobrominated ketone, 47 





Figure 4.14. Gas chromatogram of bromo indanone. 





























Figure 4.15. Mass spectrum of bromo indanone. 
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4.4.2 Diester amide of 5-methoxy indanone (48). The keto-diesteramide of indanone 47 
was synthesized by applying the same method used in the synthesis of 39 (Scheme 4.6). The 
GC/MS and 
1
H NMR spectra were consistent in the characterization of the keto-diesteramide, 
47.The GC/MS of the keto-diesteramide of indanone 47 was run isothermally to give rise to a 
single chromatogram peak at 11.64 min (Figure 4.16). The sample was run isothermally in order 
to preserve the molecular ion and therefore the appearance of the corresponding peak at m/z 377 
(Figure 4.17). The base peak at 262 min indicated the formation of acylium ion by losing the 
amide group first and then by deethylation. 
 
Figure 4.16. Gas chromatogram of diester amide of indanone. 























Figure 4.17. Mass spectrum of diester amide of indanone. 






















377 101 77 










4.4.3 Amino acids of 5-methoxy indanone (49) and 5-hydroxy indanone (50). The 
synthesis of the methoxy-indanone homolog of dopa 49 involved partial deprotection and 
decarboxylation using 50% aqueous hydrochloric acid (Figure 4.19). The synthesis of hydroxyl-
indanone homolog 50 involves the deprotection of methyl group and decarboxylation using conc. 
hydrobromic acid. The resulting products, 49 and 50 were analyzed using NMR analysis. The 

















Conclusion and Recommendations 
Many reaction conditions were applied in the synthesis of a variety of dopa homologs. In 
this work, all of the proposed dopa homologs were successfully synthesized with the exception 
of the methoxy (49) and hydroxy forms (50) of the indanone amino acids (Figure 1). Numerous 
attempts were made in synthesizing 49 and 50; as these compounds were found to be quite labile 
within the acid mediums. All precursors to the proposed dopa homologs of the diester amides 
were successfully synthesized with good-excellent percentage yields, and were all confirmed 
using GC/MS, FTIR and NMR. In summary, six precursors to the proposed dopa homologs as 
well as three proposed dopa homologs were successfully synthesized. 
Throughout this research, experimental evidence has led to the proper use of acid 
concentrations in giving rise to the greatest quantities of product yields of the desired amino 
acids. As a result, it has been determined that 50% hydrochloric acid  and concentrated 
hydrobromic acid were most effective in establishing the most effective/stable reaction medium 
in giving rise to the amino acids; with the exception of 49 and 50. 
Future prospectives of this work will involve the stereoselective synthesis, and enzymatic 
resolution of the D and L forms of relevant amino acids. The dopa homologs that were 
synthesized are expected to be tested for their inhibitory activity on melanogenesis. These same 
homologs can also be tested on brain and evaluated for their activity on the release of dopamine 
in patients suffering from psychological disorders. Additional functionalized dopa homologs are 
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C NMR of Diester amide of 5-methoxy indanone (48) 
 
